一级婬片试看120分钟,安徽少妇BBBB搡BBBB,波多野结衣一级片

国产一级婬片A片免费无成人黑豆,亚洲AV无码乱码精品,黄色网址免费在线观看,少妇高潮久久久久久潘金莲

<tr id="cc0cc"></tr>

<nav id="cc0cc"></nav><small id="cc0cc"></small>

<sup id="cc0cc"></sup>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

亚洲精品在线免费 | 99国产精品人妻人伦 | 国产做爰XXXⅩ高潮韩国 | 久久久久国产精品www | 毛片无码高清蜜桃视频 | 亚洲精品无码毛片久道具明星 | 后入内射欧美99二区视频 | 成人AAAAAAAA免费播放 | 久久成人网一区二区青椒直播 | 日本理论韩国直播视频 | 波多野50部无码喷潮影院 | 特级婬片A片AAA毛片咕噜咕噜 | 老妇裸体性激交老太视频 | 日本吞精合集手机在线观看 | 久久久久亚洲Av片无码 | 色欲AV性色av浪潮AV壹牛网 | 精品国产一级黄色片网站 | 精品人妻无码一区二区三区蜜桃一 | 精品无码一区二区Av蜜桃 | 国产成人一区二区三区 | 国产精品操操黑料影院 | 免费无码婬片A片AA片 | 国产日韩一区二区三免费高清 | 欧美videos护士性猛交 | 色婷婷综合久色aⅴ高清电视 | 日韩精品中文字幕一区二区三区 | 国产精品三区在线观看 | 少妇人妻偷人精品视频蜜桃 | 人妻熟女 – 无名网 | 亚洲爆乳无码精品AAA片蜜桃 | 国产91久久婷婷一区二区 | 人妻丰满精品一区二区三 | 汤芳一区二区三区毛片 | 南京搡BBBB搡BBBB | 日本三级片网站在线观看 | 伦精品午夜一级婬片A片 | 国产无码在线看免费看 | 少妇人妻系列1～100 | 西西www44一区二区无码视频 | 又大又粗又黄又免费观看 | 99成人乱码一区二区三区在线 |

<tfoot id="ccccc"><dd id="ccccc"></dd></tfoot>

<nav id="ccccc"></nav>

<tr id="ccccc"></tr><tr id="ccccc"></tr>

<noscript id="ccccc"><dd id="ccccc"></dd></noscript>